Investing.com’s stocks of the week

The decline comes after the results from its phase 3 trial of CagriSema, its next-generation obesity drug, disappointed investors.

Reacting to the results, analysts at Wolfe Research said: “While we didn't expect CagriSema to be a formidable competitor to Lilly's Zepbound, we now see Lilly in a true class of its own with Zepbound, orforglipron and retatrutide."While MSTR and COIN are up on Friday, +8.1% and +1%, respectively, both names have declined for most of this week. MicroStrategy is down around 14% over the last five days, while Coinbase has declined over 11%.

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

2 Thriving AI Stocks With Significantly More Upside Than NvidiaStocks Analysis by Investing.com (Jesse Cohen) covering: Nasdaq 100, NVIDIA Corporation, Twilio Inc, Zoom Video Communications Inc. Read Investing.com (Jesse Cohen)'s latest article on Investing.com
Источник: Investingcom - 🏆 450. / 53 Прочитайте больше »